Literature DB >> 1591014

A factor secreted by a human pulmonary alveolar epithelial-like cell line blocks T-cell proliferation between G1 and S phase.

R Paine1, A Chavis, D Gaposchkin, P Christensen, C H Mody, L A Turka, G B Toews.   

Abstract

Because the pulmonary alveolar space is both the site of gas exchange for respiration and a portal of entry for foreign antigen, immunologic interactions within that space must be meticulously controlled. Alveolar epithelial cells are ideally situated to play a role in immune regulation within the alveolar space. We have used A549 cells, a cell line that is derived from a human alveolar cell carcinoma and that has been used as a model for alveolar type II epithelial cells, to examine the potential role of alveolar epithelial cells in local pulmonary immune regulation. Medium conditioned by confluent monolayers of A549 cells suppressed proliferation by human peripheral blood mononuclear cells (PBMC) stimulated with lectin, anti-CD3 antibodies, calcium ionophore and phorbol ester, or in a mixed leukocyte reaction. PBMC that had been incubated in and then removed from A549-conditioned medium went on to proliferate normally. Because the suppressive effect was abrogated by heating or acidification and was not blocked by neutralizing antibody to transforming growth factor-beta 1, this effect could not be attributed to transforming growth factor-beta. The factor mediating this effect has an approximate molecular weight of 70,000 D by gel filtration chromatography. Nonalveolar, pulmonary carcinoma cell lines did not exert this immunosuppressive influence nor did the alveolar epithelial cells inhibit proliferation by the transformed, Jurkat, T-cell line. Cell cycle analysis demonstrated that PBMC exposed to A549 cell-conditioned medium failed to enter S phase after mitogen stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591014     DOI: 10.1165/ajrcmb/6.6.658

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  7 in total

1.  Regulation of T-cell activation in the lung: isolated lung T cells exhibit surface phenotypic characteristics of recent activation including down-modulated T-cell receptors, but are locked into the G0/G1 phase of the cell cycle.

Authors:  D Strickland; U R Kees; P G Holt
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells.

Authors:  A C Cunningham; J G Zhang; J V Moy; S Ali; J A Kirby
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

3.  The T cell antigen receptor CD3:CD4 molecular complex is diminished on the surface of pulmonary lymphocytes.

Authors:  K Marathias; C Pinto; G Rodberg; F Preffer; J Wong; R Kradin
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

4.  Lung lymphocyte elimination by apoptosis in the murine response to intratracheal particulate antigen.

Authors:  A M Milik; V A Buechner-Maxwell; J Sonstein; S Kim; G D Seitzman; T F Beals; J L Curtis
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  Trafficking, persistence, and activation state of adoptively transferred allogeneic and autologous Simian Immunodeficiency Virus-specific CD8(+) T cell clones during acute and chronic infection of rhesus macaques.

Authors:  Diane L Bolton; Jacob T Minang; Matthew T Trivett; Kaimei Song; Jennifer J Tuscher; Yuan Li; Michael Piatak; David O'Connor; Jeffrey D Lifson; Mario Roederer; Claes Ohlen
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

6.  Lung lymphocytes proliferate minimally in the murine pulmonary immune response to intratracheal sheep erythrocytes.

Authors:  G D Seitzman; J Sonstein; S Kim; W Choy; J L Curtis
Journal:  Am J Respir Cell Mol Biol       Date:  1998-06       Impact factor: 6.914

7.  Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products.

Authors:  B Crestani; P Cornillet; M Dehoux; C Rolland; M Guenounou; M Aubier
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.